Filter
302
Text search:
vaccine
candidates
Featured
Recommendations
34
New Publications
56
Language
Document type
No document type
96
Studies & Reports
78
Guidelines
46
Fact sheets
30
Manuals
14
Resource Platforms
12
Strategic & Response Plan
12
Videos
6
Situation Updates
3
Online Courses
3
Training Material
2
Countries / Regions
Global
18
West and Central Africa
10
India
9
East and Southern Africa
8
Middle East and North Africa
7
Sierra Leone
6
Liberia
6
Latin America and the Carribbean
6
Africa
6
Russia
6
Nigeria
5
Guinea
4
Germany
4
Kenya
4
China
4
South Africa
4
Uganda
3
South Sudan
3
Tanzania
3
Ukraine
3
USA
2
Ethiopia
2
Ghana
2
Haiti
2
Philippines
2
Nepal
2
Syria
2
Brazil
2
Myanmar / Burma
2
Congo, Democratic Republic of
1
Zambia
1
Turkey
1
Thailand
1
Rwanda
1
Indonesia
1
Bangladesh
1
Mozambique
1
North Macedonia
1
Madagascar
1
Western and Central Europe
1
Asia
1
Eastern Europe
1
Timor Leste/ East Timor
1
Kazakhstan
1
Vietnam
1
France
1
United Kingdom
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
71
Clinical Guidelines
31
Public Health
8
Key Resources
7
Women & Child Health
5
Pharmacy & Technologies
3
Capacity Building
1
Annual Report MEDBOX
1
Toolboxes
COVID-19
105
TB
25
Ebola & Marburg
17
NTDs
15
HIV
12
Rapid Response
9
Health Financing Toolbox
9
AMR
8
Malaria
8
Zika
6
Polio
4
Global Health Education
4
2.0 Rapid Response
3
Cholera
2
Conflict
2
Refugee
2
Caregiver
2
Planetary Health
2
Pharmacy
2
Disability
1
Natural Hazards
1
Mental Health
1
NCDs
1
COVID-19 vaccine tracker and landscape
recommended
The COVID-19 vaccine tracker and landscape compiles detailed information of each COVID-19 vaccine candidate in development by closely monitoring their progress through the pipeline.
The COVID-19
...
This tracker, developed by the Vaccine Centre at the London School of Hygiene & Tropical Medicine, will follow COVID-19 vaccine candidates as they
...
Scientists and researchers managed to produce vaccines to protect against COVID-19. Vaccine candidates have recently been approved in some countries and are in the approval process in others, yet mi
...
August 2020, The Africa Joint Continental Strategy for COVID-19 is underpinned by the need to limit transmission, prevent deaths and reduce associated harms. Participation by African nations in clinical trials is an essential step to ensure that sufficient data is generated on the safety and efficac
...
BioDrugs. 2023 Sep 20;37(6):737–756. doi: 10.1007/s40259-023-00623-4
There are many malaria vaccine candidates in development, with more than a dozen of these in clinical development. RTS,S/AS01
...
This chronology of facts has challenged public health systems worldwide and regulatory bodies are no exception. Regulatory authorities with mechanisms in place to authorize the use of investigational products had to development guidelines and procedures, create task forces and alliances to maximize
...
24 September 2021. The vaccine has been authorized by the Chinese National Regulatory Authority (NRA) – the National Medicinal Product Administration (NMPA) – as well as other regulatory authorities. Because WHO has granted Emergency Use Listing
...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the b
...
7 June 2021
The Africa Regulatory Taskforce is a joint effort established by the Africa Centres for Disease Control and Prevention (Africa CDC), the African Union Development Agency (AUDA-NEPAD) coordinated African Medicines Regulatory Harmonization (AMRH) Initiative, and the World Health Organisat
...
24 September 2021. The vaccine has been authorized by the Chinese National Regulatory Authority (NRA) – the National Medicinal Product Administration (NMPA) – as well as other regulatory authorities. Because WHO has granted Emergency Use Listing
...
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
10 December 2020
Many countries are using the approach of mixing vaccine doses from different manufacturers. What do we know about the safety and efficacy of this approach? What does the evidence tell us about using a fraction of the
...
Manufacturers:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
...
COVID-19 Vaccine Resource Center
recommended
A collection of resources on Covid-19 vaccines, including frequently asked questions, continuing medical education, published research, and commentary.
Comment The Lancet Volume 397, ISSUE 10269, P72-74, January 09, 2021
Published:December 08, 2020DOI:https://doi.org/10.1016/S0140-6736(20)32623-4
